FILE - This undated file image provided by Merck & Co. shows their new antiviral medication. The European Medicines Agency said it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19. In a statement on Tuesday, Nov. 23, 2021, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics and that a decision could be made within weeks on whether it might be cleared. (Merck & Co. via AP, File)
Rookie QB Daniels stars again in desert return, Commanders beat Cardinals 42-14 for 3rd straight Shares
Rescuers race to free people trapped by Hurricane Helene after storm kills at least 40 in 4 states Shares